SHL Telemedicine Ltd. (0QMX.L)

5.25 -0.10 (-1.88%) At close: 04:55PM BST

SHL Telemedicine Ltd.

Ashdar Building
90 Yigal Alon Street
Tel Aviv 6789130
Israel
972 3 561 2212
https://www.shl-telemedicine.com

Sector(s): 
Industry: 
Full-time employees: 583

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Erez Nachtomy	Chief Executive Officer	359.63k	N/A	1962
Mr. Amir Hai	Chief Financial Officer	N/A	N/A	1966
Mr. Linus Drop	Co-Managing Director of SHL Telemedizin Germany	N/A	N/A	1973
Mr. Bernd Altpeter	Co-Managing Director of SHL Telemedizin Germany	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.

Description

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices, including blood pressure, weighing, oxygen saturation level (TelePulse Oximeter), breath exhalation (TeleBreather), and sugar measuring devices; and TelePress, a remote blood pressure monitoring device for personal use. It offers its telemedicine services and devices to subscribers using electronic and telecommunication technologies. The company serves physicians, hospitals, health insurance funds, and patients. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center. The company was incorporated in 1986 and is headquartered in Tel Aviv, Israel.

Corporate governance

SHL Telemedicine Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.